CHAPEL HILL, N.C.--(BUSINESS WIRE)--Oct. 17, 2006--POZEN Inc.
(NASDAQ: POZN) announced today that it will release third quarter 2006
results on October 31, 2006, before the market opens.
The announcement will be followed by a live webcast at 11:00 a.m.
Eastern Time with a discussion by POZEN management of the financial
and business results. The webcast can be accessed on POZEN's website
at www.pozen.com and will be archived and available for replay. The
third quarter 2006 earnings release can be accessed in the News
section of POZEN's website.
POZEN is a pharmaceutical company committed to developing
therapeutic advancements for diseases with unmet medical needs where
it can improve efficacy, safety, and/or patient convenience. POZEN
focuses its efforts primarily on the development of pharmaceutical
products for the treatment of acute and chronic pain and other
pain-related conditions. POZEN has development and commercialization
alliances with GlaxoSmithKline and AstraZeneca. The company's common
stock is traded on The Nasdaq Stock Market under the symbol "POZN".
For detailed company information, including copies of this and other
press releases, see POZEN's website: www.pozen.com.
CONTACT: POZEN Inc.
Chief Financial Officer
Director, Investor Relations
SOURCE: POZEN Inc.